Old Dogs Can Learn New Tricks: Is Outpatient Remdesivir a Game Changer against Omicron?
Evidence Based Medicine presented by InpharmD™ · InpharmD™
January 20, 20226m 25s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A double-blind, randomized, placebo-controlled trial conducted to evaluate the efficacy and safety of a 3-day course of remdesivir in high-risk, non-hospitalized patients with COVID-19.